Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea-Reference-Cited by-同舟云学术

Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea

Published:2024-08-06 Issue:S1 Volume:59 Page:
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Jobanputra Aesha M.¹^ORCID,Kesavarapu Keerthana²,Naik Sreelatha³^ORCID,Ramagopal Maya⁴,Scharf Matthew T.¹⁵,Jagpal Sugeet¹

Affiliation:

1. Department of Medicine Rutgers Robert Wood Johnson Medical School, Division of Pulmonary, Critical Care, and Sleep Medicine New Brunswick New Jersey USA

2. Department of Medicine Rutgers Robert Wood Johnson Medical School, Division of Gastroenterology and Hepatology New Brunswick New Jersey USA

3. Department of Medicine Geisinger Wyoming Valley Medical Center, Division of Pulmonary, Critical Care, and Sleep Medicine Wilkes‐Barre Pennsylvania USA

4. Department of Pediatrics Rutgers Robert Wood Johnson Medical School, Division of Pediatric Pulmonary Medicine and Cystic Fibrosis Center New Brunswick New Jersey USA

5. Department of Neurology Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA

Abstract

AbstractCystic fibrosis (CF) care is evolving with the ubiquitous use of modulator therapy and resultant increase in lifespan. It is important for CF clinicians to monitor the pathologic weight gain that is concomitantly being seen as obesity is a known risk factor for multiple other diseases. In this review we focus on obesity in CF, discuss screening and lifestyle considerations, outline CF‐specific concerns with weight loss medications, and describe the vicious cycle of obesity and obstructive sleep apnea (OSA). We discuss screening and treatment for OSA, as it directly correlates with weight fluctuation. We offer interim recommendations for CF teams as they continue to care for this population.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.27163

Reference69 articles.

1. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

2. Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor

3. Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations

4. Overweight and Obesity in ΔF508 Homozygous Cystic Fibrosis

5. Energy expenditure of patients with cystic fibrosis